Atrophic Rhinitis

Atrophic rhinitis is an infectious disease of swine characterized by inflammation and progressive atrophy of the nasal turbinate bones, leading to distortion of the snout and impaired respiratory function. The condition exists in two forms: non-progressive atrophic rhinitis caused primarily by Bordetella bronchiseptica, which typically resolves as pigs mature, and progressive atrophic rhinitis (PAR) caused by toxigenic strains of Pasteurella multocida, often in combination with Bordetella, which causes permanent turbinate damage. Progressive atrophic rhinitis represents the more economically significant form due to its lasting impact on pig performance.

The disease occurs worldwide in commercial swine populations and has been recognized as a significant production-limiting condition since the mid-20th century. While control programs have reduced the prevalence and severity of atrophic rhinitis in many regions, it remains endemic in numerous herds and continues to cause economic losses through reduced growth performance. The disease primarily affects young pigs during the critical early growth period, with clinical signs typically appearing between 3 and 8 weeks of age when turbinate development is most active and susceptible to damage.

Economic impacts of atrophic rhinitis manifest primarily through reduced average daily gain and impaired feed efficiency rather than mortality. Pigs with turbinate atrophy experience chronic upper respiratory dysfunction that affects eating, drinking, and temperature regulation. Severely affected animals may require additional days to reach market weight, increasing production costs. The condition also predisposes to secondary respiratory infections by compromising nasal defense mechanisms. Carcass quality is generally unaffected, but the performance impacts during the growing period translate to significant economic losses across affected populations.

Effective control of atrophic rhinitis is achievable through integrated programs combining vaccination, management practices, and strategic antimicrobial use. Understanding the distinct roles of Bordetella bronchiseptica and toxigenic Pasteurella multocida in disease development enables targeted prevention strategies. Advances in vaccine technology and improved diagnostic methods have enhanced the industry's ability to monitor and control this condition, though vigilance remains necessary to prevent reemergence in controlled herds.

Atrophic rhinitis results from infection with specific bacterial pathogens that damage the developing nasal turbinate structures in young pigs. Bordetella bronchiseptica, a gram-negative coccobacillus, colonizes the nasal passages and produces toxins that cause initial turbinate damage. This organism alone causes non-progressive atrophic rhinitis that typically resolves as pigs mature and turbinates regenerate. However, Bordetella infection predisposes to subsequent colonization by toxigenic strains of Pasteurella multocida, which produce the dermonecrotic toxin responsible for severe, progressive, and permanent turbinate destruction.

Toxigenic Pasteurella multocida strains are distinguished by their production of a potent dermonecrotic toxin (PMT) that directly damages osteoblasts and osteoclasts, disrupting normal bone development and causing bone resorption. This toxin is encoded by the toxA gene and is the primary virulence factor responsible for progressive atrophic rhinitis. Non-toxigenic Pasteurella multocida strains commonly colonize the swine respiratory tract without causing turbinate damage. Only toxigenic type A and type D strains are associated with progressive disease, with type D strains historically most commonly implicated.

Transmission of atrophic rhinitis pathogens occurs through direct contact and aerosol spread from infected pigs. Sows carrying the organisms in their nasal passages transmit infection to piglets during the nursing period, making sow-to-piglet transmission the primary route of introduction. Infected piglets then spread bacteria to penmates through nose-to-nose contact and respiratory secretions. Environmental contamination plays a limited role, as Bordetella and Pasteurella survive poorly outside the host, though contaminated housing can harbor organisms briefly between groups.

Risk factors for atrophic rhinitis development and severity include herd infection status, environmental conditions, and pig age at exposure. Early exposure during the first weeks of life when turbinates are most vulnerable results in more severe disease. High stocking density increases transmission rates and pathogen load. Poor air quality with elevated ammonia levels damages nasal epithelium and facilitates bacterial colonization. Concurrent infections with respiratory viruses or mycoplasma may exacerbate disease. Herds with toxigenic Pasteurella multocida face greater risk of severe progressive disease than those with Bordetella alone.

The pathogenesis of progressive atrophic rhinitis involves sequential colonization and toxin-mediated bone damage. Bordetella bronchiseptica adheres to respiratory epithelium using various adhesins and produces toxins including adenylate cyclase toxin, dermonecrotic toxin, and tracheal cytotoxin that damage epithelium and cilia. This initial damage facilitates colonization by toxigenic Pasteurella multocida. The PMT toxin produced by Pasteurella acts directly on bone cells, inhibiting osteoblast differentiation while stimulating osteoclast activity, resulting in net bone resorption. The turbinate bones, which are actively developing during the first weeks of life, are particularly susceptible to this toxic effect.

Early warning signs of atrophic rhinitis in young pigs include sneezing, sniffling, and clear to mucopurulent nasal discharge. Affected piglets may show frequent rubbing of the snout against objects or pen fixtures in response to nasal irritation. Mild lacrimation (tearing) may be observed. These early signs often appear in pigs 3 to 6 weeks of age and can be mistaken for other common respiratory conditions. Careful observation of multiple animals showing similar signs helps distinguish emerging atrophic rhinitis from isolated respiratory issues.

Progressive clinical signs develop over subsequent weeks as turbinate damage advances. Sneezing becomes more frequent and may produce blood-tinged discharge in some cases. Nasal discharge thickens and may develop a purulent character. Tear staining below the eyes becomes more pronounced as nasolacrimal duct function is affected by nasal inflammation. Affected pigs may show reluctance to eat due to discomfort associated with rooting and chewing, which can be observed as hesitant feeding behavior despite apparent hunger.

Behavioral changes in pigs with atrophic rhinitis reflect chronic discomfort and impaired nasal function. Affected animals may breathe through the mouth, particularly during exertion or in warm conditions when efficient nasal cooling is most important. Snoring or stertor (noisy breathing) is common due to nasal passage obstruction. Pigs may shake their heads frequently and show signs of irritation. Reduced activity and slower eating patterns develop as the condition progresses. Affected pigs often fall behind penmates in growth despite similar access to feed and water.

Physical signs of advanced atrophic rhinitis include visible snout deformities that develop as asymmetric turbinate damage causes differential growth. Lateral deviation of the snout occurs when one side is more severely affected than the other, creating a characteristic twisted appearance. Shortening or brachygnathism (pushing upward) of the upper jaw results from bilateral symmetrical damage. Wrinkling of skin over the snout develops as underlying bone structures are lost. These external deformities are permanent indicators of severe turbinate destruction that occurred during early development.

Symptom progression follows a predictable pattern based on disease severity and pig age. Initial upper respiratory signs appear during the nursing period or shortly after weaning. Progressive nasal distortion develops over the subsequent 4 to 12 weeks as turbinate damage accumulates. By 10 to 12 weeks of age, the degree of snout deformity stabilizes as turbinate development is complete, though residual effects on respiratory function persist. Chronic effects including reduced growth rate and susceptibility to secondary respiratory infections continue throughout the growing period.

Emergency symptoms are uncommon in atrophic rhinitis as the condition causes chronic rather than acute illness. However, veterinary attention is warranted when severe epistaxis (nosebleed) occurs, as this may indicate extensive turbinate erosion or concurrent disease. Rapid deterioration of respiratory function or development of severe pneumonia suggests secondary bacterial invasion requiring intervention. Outbreaks with high morbidity among young pigs should prompt immediate diagnostic investigation and implementation of control measures before widespread turbinate damage occurs.

Clinical diagnosis of atrophic rhinitis is based on recognition of characteristic upper respiratory signs in young pigs and identification of snout deformities in older affected animals. The combination of sneezing, nasal discharge, and tear staining in nursing or recently weaned pigs strongly suggests the condition. Visible snout deviation or shortening in grower pigs confirms the diagnosis clinically. Herd history of similar signs in previous groups supports the diagnosis. However, clinical evaluation alone cannot distinguish non-progressive from progressive forms or identify specific causative organisms.

Laboratory diagnosis confirms the presence of causative pathogens and characterizes the infection type. Nasal swab samples from affected pigs can be cultured to isolate Bordetella bronchiseptica and Pasteurella multocida. Identification of Pasteurella isolates as toxigenic (toxA gene positive) versus non-toxigenic is critical for assessing disease risk and guiding control strategies. PCR-based methods enable rapid detection of both organisms and specific identification of toxigenic Pasteurella strains directly from swab samples. Serological testing can detect antibodies against Bordetella and Pasteurella but is less useful for active disease diagnosis.

Necropsy and turbinate examination provide definitive assessment of disease severity and lesion character. Cross-sectional cuts of the snout at the level of the first or second premolar teeth reveal turbinate architecture. Normal turbinates appear as delicate scroll-like structures filling the nasal passages, while atrophic turbinates show various degrees of size reduction, distortion, or complete loss. Scoring systems grade turbinate atrophy from 0 (normal) to 4 (complete absence), enabling standardized assessment and comparison. Slaughter surveillance using snout sectioning provides valuable herd-level monitoring data.

Differential diagnosis includes other causes of upper respiratory disease in young pigs. Inclusion body rhinitis (porcine cytomegalovirus) causes sneezing and nasal discharge but does not produce turbinate atrophy or snout deformity. Swine influenza causes acute respiratory disease with different clinical patterns. Dust and ammonia irritation can produce similar early respiratory signs. Necrotic rhinitis from fighting or trauma requires differentiation. Complete diagnostic workup including bacterial culture, toxin gene detection, and turbinate evaluation ensures accurate diagnosis and appropriate control measure selection.

Treatment of established atrophic rhinitis focuses on controlling bacterial infection and preventing disease progression, as turbinate damage already present cannot be reversed. Early intervention before extensive bone damage occurs offers the best opportunity to limit disease severity. Once significant turbinate atrophy has developed, treatment reduces ongoing infection but cannot restore normal nasal architecture. This fundamental limitation emphasizes the importance of prevention over treatment for optimal disease control.

Antimicrobial therapy targets Bordetella bronchiseptica and Pasteurella multocida to reduce bacterial load and toxin production. Injectable antimicrobials including ceftiofur, tulathromycin, and florfenicol can be administered to clinically affected individuals. Oral medication through water or feed provides population-level coverage during outbreaks. Sulfonamide-trimethoprim combinations, tetracyclines, and tiamulin have activity against causative organisms. Antimicrobial selection should be based on susceptibility testing when possible, as resistance patterns vary among herds. Treatment duration typically ranges from 5 to 14 days depending on product and administration route.

Strategic medication programs target critical periods when infection transmission and turbinate damage risk are highest. Treatment of sows before farrowing reduces shedding to piglets during the vulnerable early nursing period. Medication of piglets at processing or weaning interrupts the disease cycle during high-transmission periods. These targeted approaches are more effective than continuous medication and support antimicrobial stewardship goals. Medication programs should be integrated with vaccination for optimal control.

Supportive care for affected pigs focuses on optimizing environmental conditions and nutrition to minimize disease impact on performance. Ensuring excellent air quality through proper ventilation reduces respiratory irritation and secondary infection risk. Providing easily accessible feed and water accommodates pigs with impaired nasal function that may have difficulty competing at feeders. Reducing stocking density decreases transmission pressure and improves per-pig resource availability. Hospital pens may be appropriate for severely affected individuals requiring individual attention.

Herd treatment protocols during outbreaks combine individual treatment of clinical cases with population-level interventions to control spread. Mass medication through water delivery reaches affected animals quickly and can be implemented immediately upon outbreak recognition. Follow-up with in-feed medication provides sustained coverage during the high-risk period. Concurrent vaccination of sows and piglets accelerates immunity development. Environmental management improvements reduce transmission efficiency. These combined approaches typically bring outbreaks under control within several weeks, though some affected animals will have permanent turbinate damage.

Treatment decisions should consider that prevention is far more effective than treatment for atrophic rhinitis. Antimicrobial treatment cannot reverse turbinate damage already sustained, so affected animals may have permanent performance impairment despite successful infection control. Economic analysis may support investment in vaccination and management improvements rather than intensive treatment programs. Working with the herd veterinarian to develop integrated control strategies ensures efficient resource allocation and optimal long-term outcomes.

Recovery from atrophic rhinitis depends on disease form and severity of turbinate damage at the time of intervention. Pigs with non-progressive atrophic rhinitis caused by Bordetella alone typically show clinical improvement within 2 to 4 weeks of treatment and may regenerate turbinate tissue as they mature. This regeneration potential is greatest when infection is controlled before extensive damage occurs. Progressive atrophic rhinitis caused by toxigenic Pasteurella results in permanent turbinate loss that does not regenerate regardless of treatment timing or success.

Post-treatment monitoring should assess clinical sign resolution and growth performance recovery. Cessation of sneezing and nasal discharge indicates successful infection control. Feed intake and daily gain should improve within 1 to 2 weeks of treatment in responsive animals. Monitoring growth rates compared to unaffected contemporaries quantifies residual performance impact. Snout deformities present at the time of treatment will persist, as these reflect permanent structural damage rather than ongoing active disease.

Prognosis for individual animals depends on severity of turbinate atrophy at diagnosis. Mildly affected pigs with minimal turbinate damage can recover to near-normal performance if infection is controlled early. Moderate cases may show 5-10% reduction in growth rate despite successful treatment. Severely affected animals with pronounced snout deviation or shortening will experience chronic performance impairment and may be candidates for early culling rather than finishing to full market weight. Visual grading of snout deformity provides rough prognosis guidance.

Return to production considerations include assessment of whether affected pigs can achieve satisfactory market weights and grades. Pigs with mild to moderate atrophic rhinitis can typically be finished successfully, though they may require additional time to reach target weights. Severely deformed animals may not achieve acceptable growth and can be culled early. For breeding stock, affected animals should not be retained as replacements, as they may harbor pathogens and transmit infection to offspring. Focus should shift to preventing disease in subsequent groups rather than salvaging affected animals.

Vaccination represents the cornerstone of atrophic rhinitis prevention and has dramatically reduced disease prevalence in commercial swine production. Vaccines containing Bordetella bronchiseptica bacterin and inactivated Pasteurella multocida toxin provide protection against both causative organisms. Sow vaccination before farrowing transfers maternal antibodies to piglets through colostrum, providing protection during the critical early vulnerable period. Piglet vaccination at or after weaning boosts immunity as maternal antibodies wane. Vaccine protocols should be tailored to herd-specific disease pressure and timing.

Biosecurity measures prevent introduction of virulent pathogen strains into herds with low disease pressure. Sourcing replacement gilts from herds with documented atrophic rhinitis-free or controlled status reduces introduction risk. Quarantine of incoming animals with clinical observation and potentially nasal culture helps identify infected animals before introduction. Maintaining closed herds when possible eliminates the primary route of new pathogen introduction. These measures are particularly important for maintaining herds that have successfully eliminated toxigenic Pasteurella multocida.

Environmental management supports respiratory health and reduces disease severity when exposure occurs. Ventilation systems should maintain air quality with ammonia levels below 25 ppm and minimal dust. Temperature control prevents chilling of young pigs that may increase susceptibility. Stocking density within recommended limits reduces transmission pressure. All-in-all-out pig flow with thorough cleaning between groups breaks cycles of endemic infection. Attention to these environmental factors complements vaccination in comprehensive control programs.

Medication strategies provide additional protection during high-risk periods when vaccination alone may be insufficient. Strategic treatment of sows before farrowing reduces shedding to newborn piglets. Piglet medication at processing or weaning provides direct protection during vulnerable periods. These interventions are most valuable during initial control program implementation or when disease pressure is high. As vaccination programs take effect and infection prevalence decreases, medication intensity can often be reduced.

Monitoring and surveillance maintain awareness of herd atrophic rhinitis status and enable early detection of control program failures. Regular slaughter checks with turbinate scoring provide objective assessment of subclinical disease. Clinical observation of young pigs identifies emerging problems before extensive damage occurs. Periodic nasal culture or PCR testing confirms continued absence of toxigenic Pasteurella in controlled herds. This surveillance enables timely response if disease status changes.

Daily management and monitoring for atrophic rhinitis requires attention to respiratory signs in young pigs during the critical early growth period. Personnel should observe piglets during the nursing period and after weaning for sneezing, nasal discharge, and tear staining that may indicate developing disease. Early recognition enables timely intervention before extensive turbinate damage occurs. Training farm staff to recognize early signs and report findings promptly supports effective disease control. Documentation of clinical observations creates records supporting trend analysis and program evaluation.

Housing and environmental management directly impact atrophic rhinitis transmission and severity. Farrowing facilities should provide clean, dry, temperature-controlled environments for newborn piglets during the most vulnerable period. Nursery and grower facilities require ventilation systems capable of maintaining excellent air quality with minimal ammonia and dust. Heating systems must prevent chilling without creating drafts. Flooring and manure management should minimize environmental pathogen accumulation. Investment in facility improvements often provides excellent return through reduced respiratory disease.

Herd health programs addressing atrophic rhinitis integrate surveillance, vaccination, medication, and management components. Slaughter surveillance programs with routine turbinate scoring provide objective herd-level disease assessment. Vaccination protocols specify products, timing, and target populations based on herd-specific needs. Strategic medication programs define intervention points and products for high-risk periods. Regular program review with the herd veterinarian evaluates effectiveness and identifies needed adjustments. Documentation of all program components ensures consistency and enables evaluation.

Record keeping for atrophic rhinitis control includes vaccination records, medication usage, clinical observations, and surveillance results. Vaccination documentation confirms protocol compliance and enables correlation with outcomes. Treatment records support antimicrobial stewardship and withdrawal time compliance. Clinical observation logs track disease trends over time. Slaughter surveillance data provide objective outcome measures. Integration of these records enables comprehensive program evaluation and continuous improvement.

Economic considerations in atrophic rhinitis management include costs of prevention measures balanced against production impacts of disease. Vaccination programs represent modest per-pig costs but provide substantial protection against performance losses. Environmental improvements require capital investment but benefit overall respiratory health beyond atrophic rhinitis alone. Economic analysis comparing prevention costs to documented disease losses helps justify program investments. Working with veterinarians and production advisors ensures economically optimized control strategies.

All commercial breeds and genetic lines of domestic swine are susceptible to atrophic rhinitis, with no breeds demonstrating natural resistance to the causative organisms or their toxins. The disease affects pigs across the genetic spectrum from heritage breeds to modern high-lean commercial genetics. While individual variation in disease susceptibility exists within populations, breed is not a significant determinant of atrophic rhinitis risk compared to infection status, management factors, and vaccination program implementation.

Production type and management system influence atrophic rhinitis risk more than genetic factors. Intensive confinement systems with continuous pig flow historically had higher disease prevalence than batch-farrowing operations with all-in-all-out management. Multi-site production systems that separate age groups reduce transmission from older carrier animals to susceptible young pigs. Outdoor and extensive systems may have lower disease pressure due to reduced stocking density and improved air quality. Current disease prevalence in well-managed herds of any type can be very low with appropriate vaccination and management programs.

Genetic selection has not specifically targeted atrophic rhinitis resistance, as prevention through vaccination and management is highly effective. Breeding companies do not offer atrophic rhinitis-resistant genetic lines. Research has not identified major genes or genetic markers associated with resistance. Selection for overall robustness and immune competence may provide indirect benefits. Producers should address atrophic rhinitis risk through vaccination, biosecurity, and environmental management rather than seeking genetic solutions.

Commonly co-occurring conditions with atrophic rhinitis include other respiratory pathogens that may predispose to or complicate the primary disease. Mycoplasma hyopneumoniae commonly infects swine populations and may be present in herds with atrophic rhinitis. Swine influenza virus causes periodic respiratory outbreaks that can occur in any herd. Porcine reproductive and respiratory syndrome (PRRS) significantly impacts respiratory health and may worsen outcomes when present with atrophic rhinitis. Streptococcus suis can cause secondary infections in pigs with compromised upper respiratory defenses. Management of the overall respiratory disease complex requires attention to multiple pathogens.

Conditions with similar upper respiratory presentations require differentiation from atrophic rhinitis. Inclusion body rhinitis caused by porcine cytomegalovirus produces sneezing and nasal discharge in young pigs but does not cause turbinate atrophy or snout deformity. Dust and ammonia irritation causes sneezing without infectious etiology. Necrotic rhinitis from fighting results in localized nasal damage distinct from the bilateral turbinate involvement of atrophic rhinitis. Pseudorabies can cause respiratory signs but is accompanied by neurological manifestations and systemic illness. Complete diagnostic workup differentiates these conditions.

Complications and sequelae of atrophic rhinitis relate primarily to chronic effects of turbinate loss on respiratory function. Pigs with severe turbinate atrophy may have increased susceptibility to secondary respiratory infections due to impaired nasal filtering and conditioning of inspired air. Chronic mouth breathing can occur in severely affected animals. Growth performance impacts persist throughout the finishing period even after active infection is controlled. Snout deformities are permanent and may affect competitive ability at feeders and waterers. These chronic effects emphasize the importance of prevention over treatment.